AARON RUBENSTEIN: Open Payments
NPI 1194363234 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,038 in 185 payments from 22 companies in 2025. Trend: 2023 $413 · 2024 $1,598 · 2025 $3,038
Food & beverage: $2,995Education: $43
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 46 | $638 |
| AstraZeneca Pharmaceuticals LP | 22 | $445 |
| Verona Pharma, Inc. | 24 | $325 |
| GENZYME CORPORATION | 12 | $216 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $212 |
| JAZZ PHARMACEUTICALS INC. | 8 | $172 |
| Insmed, Inc. | 9 | $165 |
| Regeneron Healthcare Solutions, Inc. | 10 | $155 |
| Amgen Inc. | 6 | $92 |
| HARMONY BIOSCIENCES LLC | 5 | $91 |
Products named: NUCALA, DUPIXENT, Ohtuvayre, ARALAST, TRELEGY ELLIPTA, XYWAV, BREZTRI, Arikayce.
Industry payments across NJ — which companies pay providers there.
